Longevity Return On Assets from 2010 to 2025
| XAGE Stock | 0.83 0.08 10.67% |
Return On Assets | First Reported 2010-12-31 | Previous Quarter (7.03) | Current Value (7.39) | Quarterly Volatility 1.5151784 |
Check Longevity Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Longevity Health's main balance sheet or income statement drivers, such as Depreciation And Amortization of 161.3 K, Interest Expense of 46.6 K or Selling General Administrative of 2.9 M, as well as many indicators such as Price To Sales Ratio of 2.8 K, Dividend Yield of 0.0 or Days Sales Outstanding of 1.8 K. Longevity financial statements analysis is a perfect complement when working with Longevity Health Valuation or Volatility modules.
Longevity | Return On Assets | Build AI portfolio with Longevity Stock |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Longevity Health Hol is a strong investment it is important to analyze Longevity Health's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Longevity Health's future performance. For an informed investment choice regarding Longevity Stock, refer to the following important reports:Check out the analysis of Longevity Health Correlation against competitors. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Longevity Health. If investors know Longevity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Longevity Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Longevity Health Hol is measured differently than its book value, which is the value of Longevity that is recorded on the company's balance sheet. Investors also form their own opinion of Longevity Health's value that differs from its market value or its book value, called intrinsic value, which is Longevity Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Longevity Health's market value can be influenced by many factors that don't directly affect Longevity Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Longevity Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Longevity Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Longevity Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.